Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies

@article{Man2015ExposureTS,
  title={Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies},
  author={Kenneth K C Man and Henry Hoi-Yee Tong and Lisa Y. L. Wong and Esther W Y Chan and Ian C. K. Wong},
  journal={Neuroscience \& Biobehavioral Reviews},
  year={2015},
  volume={49},
  pages={82-89}
}
This study is a critical analysis of the association between selective serotonin reuptake inhibitors (SSRIs) exposure during pregnancy and autism spectrum disorder (ASD) risk in children. Electronic databases were searched for observational studies published from January 1946 to June 2014 related to the association between SSRI exposure during pregnancy and ASD in children. Studies relevant to the association between SSRI exposure during pregnancy and ASD in children were extracted and compiled… 
Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis.
TLDR
It is suggested that confounding by indication still cannot be ruled out regarding prenatal SSRI exposure and ASD in children and negative/inconsistent findings among cohort studies weaken the significant associations detected in this meta-analysis.
Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis.
TLDR
It is concluded that SSRI use in pregnancy is associated with an increased risk of ASD in the offspring, but maternal psychiatric condition is a major confounding factor.
Association between maternal antidepressant use during pregnancy and autism spectrum disorder: an updated meta-analysis
TLDR
An updated meta-analysis of the association between maternal antidepressant use during pregnancy and autism spectrum disorder in children exposed in utero to antidepressant found no significant association.
Risk for Autism Spectrum Disorders According to Period of Prenatal Antidepressant Exposure: A Systematic Review and Meta-analysis
TLDR
There is a significant association between increased ASD risk and maternal use of antidepressants during pregnancy; however, it appears to be more consistent during the preconception period than during each trimester.
Title: Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis
(164 words) This systematic review assesses the association between prenatal antidepressant exposure and risk of ADHD in children. Electronic databases were searched up to 25 July 2017. Observational
Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis
TLDR
The data suggest that the observed association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication because the results from sibling‐matched analyses do not support an increased risk ofADHD in discordant exposed siblings.
Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.
TLDR
There appears to be a link between serotonin reuptake inhibition in pregnancy and developmental delay and spectrum disorders in infancy leading to cognitive difficulties in childhood.
Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations
TLDR
Existing observational studies measuring the risk of ASD and ADHD with antidepressant exposure are heterogeneous in their design and classical comparisons between exposed and unexposed women during pregnancy are at high risk of residual confounding.
Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta‐analysis of cohort studies
TLDR
An exclusive meta-analysis of cohort studies investigating the possible link between prenatal selective serotonin reuptake inhibitor exposure and autism spectrum disorders in children showed a significant association with ASD which strengthens the previous suggestion of confounding by indication.
University of Dundee Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder
Background: Antidepressant exposure during pregnancy has been associated with an increased risk of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in several
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
TLDR
A cohort study of all singleton live births in Denmark from 1996 through 2005, with follow-up through 2009, did not detect a significant association between maternal use of SSRIs during pregnancy and autism spectrum disorder in the offspring.
Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations
TLDR
Fluxetine and paroxetine should be avoided in the first trimester and among those at risk of an unplanned pregnancy and the teratogenic effect of individual SSRIs has not been compared using meta-analysis.
In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
TLDR
Evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD is found and these results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.
Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay
TLDR
In boys, prenatal exposure to SSRIs may increase susceptibility to ASD or DD, and the benefits of prenatal SSRI use should be carefully weighed against potential harms.
Antidepressant exposure in pregnancy and risk of autism spectrum disorders
TLDR
There was no significant association between prenatal exposure to antidepressant medication and autism spectrum disorders in the offspring after controlling for important confounding factors.
A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.
TLDR
Antidepressant use during pregnancy significantly increases the risk for LBW andPTB and there was a significant association between antidepressant exposure and PTB for different types of control status used (depressed, mixed or nondepressed).
Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study
TLDR
In utero exposure to both SSRIs and non-selective monoamine reuptake inhibitors (tricyclic antidepressants) was associated with an increased risk of autism spectrum disorders, particularly without intellectual disability.
Antidepressant use during pregnancy and childhood autism spectrum disorders.
TLDR
Although the number of children exposed prenatally to selective serotonin reuptake inhibitors in this population was low, results suggest that exposure, especially during the first trimester, may modestly increase the risk of ASD.
Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)
TLDR
Prevalence of autism and related ASDs is substantially greater than previously recognised and services in health, education, and social care will need to recognise the needs of children with some form of ASD, who constitute 1% of the child population.
Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.
TLDR
Transfer of SSRIs and SNRIs across the placenta was substantial and neonates developed mild behavioral symptoms in the early perinatal period but these were self-limiting and similar for both SSRIS and the SNRI venlafaxine.
...
1
2
3
...